Services

CNS is a full service CRO specialising in early stage clinical trials in Australia and New Zealand, a region that offers a fast and pragmatic regulatory pathway to the clinic and early stage trials. CNS is unique in Australia through offering a complete pathway from the preclinical planning and implementation right up to clinical proof of concept trials and beyond – all tailored specifically towards SME biotechs.

CNS offers its early stage clinical trials services under the Fast2First brand. This brand has been developed in collaboration with two other Australasian CROs (CPR Pharma Services (CPR), Adelaide, Australia, and Beltas, Auckland, New Zealand) under the TriAlliance strategic partnership.

CNS also recently launched BioDesk, a unique global product development and regulatory planning consultancy positioned to take biotechnology companies efficiently through preclinical/CMC, allowing earlier entry into human safety & proof-of-concept clinical trials and beyond!